Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Recurrence Among Low Risk Endometrial Cancer Population

NCT04604613 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT04604613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04604613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Recurrence Among Low Risk Endometrial Cancer Population
Lead sponsor
M.D. Anderson Cancer Center
Phase
Observational
Overall status
Active, not recruiting
Start date
November 8, 2012
Completion date
December 31, 2026
Enrollment
518 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

figo grade 1 endometrial endometrioid adenocarcinoma, figo grade 2 endometrial endometrioid adenocarcinoma